Regulatory T cells in atherogenesis.

Area of Science:

• Immunology
• Cardiovascular Research
• Inflammation Biology

Background:

• Atherosclerosis is an inflammatory arterial disease involving immune cells.
• T cells play a critical role in accelerating atherosclerosis.
• Regulatory T cells (Tregs) are crucial for immune tolerance and inhibiting atherosclerosis.

Purpose of the Study:

• To review the role of Tregs in preventing atherosclerosis.
• To explore therapeutic strategies for atherosclerotic diseases by promoting regulatory immune responses.
• To highlight oral immune modulation as a potential treatment.

Main Methods:

• Review of recent scientific literature on Tregs and atherosclerosis.
• Analysis of the balance between effector T cells and Tregs in atherogenesis.
• Investigation of peripheral Treg generation in gut-associated lymphoid tissues.

Main Results:

• Tregs actively inhibit atherosclerosis development by down-regulating effector T-cell responses.
• An imbalance between effector T cells and Tregs is characteristic of atherosclerotic conditions.
• Gut-associated lymphoid tissues are key sites for generating peripherally inducible Tregs.

Conclusions:

• Promoting endogenous regulatory immune responses, particularly via oral immune modulation, is a promising therapeutic strategy.
• Intervention in the gut environment can foster regulatory immune responses to suppress atherosclerotic diseases.
• Understanding Treg function offers new avenues for preventing and treating atherosclerosis.